5-HT 3 antagonists (Albany Molecular Research)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Name5-HT 3 antagonists (Albany Molecular Research)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 3 (5-HT3) receptor antagonists
TargetsSerotonin 3 (5-HT3) receptor
Therapy Area/IndicationsChemotherapy-induced nausea and vomitingIrritable Bowel Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAlbany Molecular Research Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAlbany Molecular Research Inc
Active IndicationsN/A
Inactive IndicationsChemotherapy-induced nausea and vomitingIrritable Bowel Syndrome

Other Information

ATC CodeN/A
Related LinksN/A